Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial.

Abstract

AIMS This study sought to investigate the 2-year outcomes of patients treated with the paclitaxel-eluting TAXUS((R)) stent (PES) or vascular brachytherapy (VBT), the previous 'gold standard therapy', for bare metal stent in-stent restenosis (ISR). METHODS AND RESULTS In the TAXUS V-ISR trial, 396 patients with bare metal stent ISR referred for… (More)
DOI: 10.1093/eurheartj/ehn231

Topics

8 Figures and Tables